Updates are available Correction dated 2022-03-24
Click to view Correction: https://doi.org/10.1038/s41586-022-04653-w
-
Authors
Thorne, Lucy G. https://orcid.org/0000-0001-7358-6047
Bouhaddou, Mehdi
Reuschl, Ann-Kathrin
Zuliani-Alvarez, Lorena
Polacco, Ben https://orcid.org/0000-0003-1570-9234
Pelin, Adrian
Batra, Jyoti
Whelan, Matthew V. X.
Hosmillo, Myra
Fossati, Andrea https://orcid.org/0000-0001-5170-4903
Ragazzini, Roberta https://orcid.org/0000-0003-2186-293X
Jungreis, Irwin https://orcid.org/0000-0002-3197-5367
Ummadi, Manisha
Rojc, Ajda
Turner, Jane
Bischof, Marie L.
Obernier, Kirsten https://orcid.org/0000-0002-4025-1299
Braberg, Hannes https://orcid.org/0000-0002-7070-2257
Soucheray, Margaret
Richards, Alicia
Chen, Kuei-Ho https://orcid.org/0000-0001-6541-0578
Harjai, Bhavya
Memon, Danish https://orcid.org/0000-0002-1365-0710
Hiatt, Joseph
Rosales, Romel
McGovern, Briana L. https://orcid.org/0000-0002-0492-9904
Jahun, Aminu https://orcid.org/0000-0002-4585-1701
Fabius, Jacqueline M.
White, Kris https://orcid.org/0000-0003-0889-0506
Goodfellow, Ian G. https://orcid.org/0000-0002-9483-510X
Takeuchi, Yasu
Bonfanti, Paola https://orcid.org/0000-0001-9655-3766
Shokat, Kevan https://orcid.org/0000-0001-8590-7741
Jura, Natalia https://orcid.org/0000-0001-5129-641X
Verba, Klim https://orcid.org/0000-0002-2238-8590
Noursadeghi, Mahdad https://orcid.org/0000-0002-4774-0853
Beltrao, Pedro
Kellis, Manolis https://orcid.org/0000-0001-7113-9630
Swaney, Danielle L. https://orcid.org/0000-0001-6119-6084
García-Sastre, Adolfo https://orcid.org/0000-0002-6551-1827
Jolly, Clare https://orcid.org/0000-0002-4603-2281
Towers, Greg J. https://orcid.org/0000-0002-7707-0264
Krogan, Nevan J. https://orcid.org/0000-0003-4902-337X
- License Information
-
More Information
Article History
Received: 31 May 2021
Accepted: 14 December 2021
First Online: 23 December 2021
Change Date: 24 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-022-04653-w
Competing interests
: The N.J.K. laboratory has received research support from Vir Biotechnology and F. Hoffmann-La Roche. N.J.K. has consulting agreements with the Icahn School of Medicine at Mount Sinai, New York, Maze Therapeutics and Interline Therapeutics. He is a shareholder in Tenaya Therapeutics, Maze Therapeutics and Interline Therapeutics, has received stocks from Maze Therapeutics and Interline Therapeutics and is a financially compensated Scientific Advisory Board Member for GEn1E Lifesciences. The A.G.-S. laboratory has received research support from Pfizer, Senhwa Biosciences, Kenall Manufacturing, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold, Model Medicines, Atea Pharma and Merck. A.G.-S. has consulting agreements for the following companies involving cash and/or stock: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, Paratus and Pfizer. A.G.-S. is inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections, owned by the Icahn School of Medicine at Mount Sinai, New York.
